Heinrich-Heine-Universität Düsseldorf

Event Report 7th Scientific Symposium of AGO-TraFo (2016) Niederacher D, Fasching P, Fehm TN Journal article Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans (2016) Schipp C, Nabhani S, Bienemann K, Simanovsky N, Kfir-Erenfeld S, Assayag-Asherie N, Oommen PT, et al. Journal article Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015 (2016) Schnuerch HG, Ackermann S, Alt CD, Barinoff J, Boeing C, Dannecker C, Gieseking F, et al. Journal article Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer (2016) Janni WJ, Rack B, Terstappen LWMM, Pierga JY, Taran FA, Fehm T, Hall C, et al. Journal article Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates (2016) Van Der Ven H, Liebenthron J, Beckmann M, Toth B, Korell M, Kruessel J, Frambach T, et al. Journal article Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial (2016) Schroeder L, Rack B, Sommer H, Koch JG, Weissenbacher T, Janni W, Schneeweiss A, et al. Journal article The International Endometriosis Evaluation Program (IEEP Study) - A Systematic Study for Physicians, Researchers and Patients (2016) Burghaus S, Fehm T, Fasching P, Blum S, Renner S, Baier F, Brodkorb T, et al. Journal article Report on the 5th symposium of the German research network bladder carcinoma (2016) Fuessel S, Kramer MW, Stoehr R, Olbert P, Nawroth R, Schulz WA Journal article, Report Role of the receptor Mas in macrophage-mediated inflammation in vivo (2016) Hammer A, Yang G, Friedrich J, Kovacs A, Lee DH, Grave K, Joerg S, et al. Journal article Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab (2016) Ziemssen T, Gass A, Wuerfel J, Bayas A, Tackenberg B, Limmroth V, Linker R, et al. Journal article